Scribe Therapeutics, Inc. (SCTX) Financial Statements

Scribe Therapeutics, Inc. (SCTX) files with the U.S. Securities and Exchange Commission under CIK 0001853921. 10KGenie shows its quarterly statements from SEC filings.

No annual key figures are available in 10KGenie for this company yet. Source: SEC filings.

Open the full financial statements for SCTX in 10KGenie

Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History